Infectious disease doctor says "there's really no evidence" that hepatitis B vaccine "causes harm"

Key Concepts

• Hepatitis B vaccine
• Newborn vaccination
• Liver scarring, liver failure, liver transplantation, death
• Hepatitis B transmission
• CDC (Centers for Disease Control)
• Vaccine recommendations and insurance coverage
• Childhood vaccine schedule
• Immune system development in infants
• Vaccine ingredients (adjuvants)
• Measles, whooping cough, polio
• Robert F. Kennedy Jr.'s claims on vaccine ingredients and health issues

Hepatitis B Vaccine Recommendation and CDC Vote

The Centers for Disease Control (CDC) has delayed a vote on a long-standing recommendation for the hepatitis B vaccine. Currently, the standard recommendation is for every baby to receive at least the first dose of the hepatitis B vaccine within 24 hours of birth. While this vote would not prohibit doctors from administering the vaccine, it could potentially influence insurance coverage for the vaccine.

Rationale for Newborn Hepatitis B Vaccination

Dr. Peter Chin Hong, an infectious disease specialist at the University of California, San Francisco, explained the critical importance of vaccinating all babies against hepatitis B shortly after birth.

• Severity of Hepatitis B: Hepatitis B is a potentially dangerous virus. The primary concern is not just the infection itself, but the long-term consequences, which can include liver scarring, liver failure, the need for liver transplantation, and even death.
• Increased Risk with Early Infection: The risk of these severe complications is significantly higher if a baby is infected with hepatitis B right after birth.
• Limitations of Screening: Currently, only about one in five pregnant individuals are screened for hepatitis B. Relying solely on screening to determine who needs the vaccine is therefore considered potentially dangerous, as many infected mothers may not be identified.
• Transmission Pathways: Babies can contract hepatitis B from their mothers during birth (passage through the birth canal). Additionally, they can acquire the virus from family members who may be infected but unaware of their status.
• High Transmissibility: Hepatitis B is highly transmissible, being "100 times more transmissible than HIV." The virus can survive in dried blood on surfaces like toothbrushes for up to a week, highlighting its environmental persistence.

Addressing Concerns About Vaccine Safety and Necessity

Concerns have been raised by some members of the CDC panel regarding the hepatitis B vaccine being administered to babies who may not "need it" and potential links to severe health complications.

• Lack of Evidence for Harm: Dr. Chin Hong stated that there is "really no evidence that it causes harm."
• Overwhelming Evidence of Benefit: Conversely, there is substantial evidence demonstrating the vaccine's benefits.
  • Historical Data: Before the routine vaccination at birth policy was implemented in the early 1990s, there were approximately 20,000 cases of hepatitis B at birth annually. This number has since decreased to about 20 cases per year, which Dr. Chin Hong described as "probably the most powerful evidence that it works."
  • Global Adoption: Over a hundred countries have adopted birth vaccination for hepatitis B, indicating its recognized efficacy and feasibility with adequate infrastructure.
• Weighing Risks and Benefits: Dr. Chin Hong emphasized that the evidence of benefit "rather than the potential downside as in a safety problem or issue" is significant.

Childhood Vaccine Schedule and Immune System Development

The CDC committee is also expected to discuss the broader childhood vaccine schedule.

• Repercussions of Lowered Vaccination Rates: Dr. Chin Hong highlighted the current repercussions of declining vaccination rates, citing outbreaks of measles and whooping cough. He also warned of the potential resurgence of diseases like polio, which have been largely forgotten due to successful vaccination programs.
• Importance of the Schedule: The current vaccine schedule is crucial because it is designed to align with the developing immune system of infants.
  • Immune System Responsiveness: A baby's immune system is "very new" and "sluggish." It requires multiple doses or specific timing to effectively develop antibody responses.
  • Disease-Specific Needs: Some diseases, like whooping cough, require multiple vaccine doses. Attempting to consolidate all vaccinations into a single time or age group would not be optimal from an immunological perspective.

Response to Claims About Vaccine Ingredients

Dr. Chin Hong addressed claims made by Health Secretary Robert F. Kennedy Jr. regarding vaccine ingredients and their potential to cause health issues like increased allergies due to an "elevated immune response."

• Lack of Scientific Support: Dr. Chin Hong stated that "the scientific evidence doesn't show any of this."
• Long-Term Safety Data: He reiterated that this is not a new area of study, and "decades of information around this" have consistently shown vaccines to be safe.
• Role of Adjuvants: He explained the necessity of adjuvants, describing them as "extra sauce to make the immune system more responsive," particularly in infants whose immune systems are still developing and are inherently sluggish.

Conclusion

The discussion underscores the critical importance of the hepatitis B vaccine for newborns, supported by decades of data demonstrating its effectiveness in preventing severe liver disease and death. While concerns about vaccine safety are acknowledged, the overwhelming scientific consensus points to the benefits far outweighing any unsubstantiated risks. The current childhood vaccine schedule is also presented as a carefully considered framework designed to optimize immune response in developing infants, with a warning about the potential resurgence of preventable diseases if vaccination rates decline.